Nordea Investment Management
BIVV

Nordea Investment Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Nordea Investment Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-48,387
Closed -$2.61M – 1094
2017
Q4 		$2.61M Buy
48,387
+11,008
+29% +$602K 0.01% 558
2017
Q3 		$2.13M Buy
+37,379
New +$2.19M 0.01% 665
2017
Q2 		– Sell
-8,651
Closed -$471K – 1095
2017
Q1 		$471K Buy
+8,651
New +$426K ﹤0.01% 861

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Nordea Investment Management's BIVV Position: Q1 2018 in Review

Nordea Investment Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 48,387 shares — an estimated $2.61M sold.

Nordea Investment Management first reported a position in BIVV in Q1 2017 and held it in 3 quarters. The position peaked at $2.61M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Nordea Investment Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Nordea Investment Management sold 48,387 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2.61M.
  • Nordea Investment Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 3 quarters.
  • Nordea Investment Management's Bioverativ Inc. Common Stock position peaked at $2.61M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Nordea Investment Management's 13F filing for Q1 2018, filed 14 May 2018.